إعلان
إعلان
CSTL
Castle Biosciences, Inc. Common Stock
39.34
USDبرعاية
-0.55
-1.38%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
39.36
+0.02
+0.05%
تقارير أرباح CSTL
النسبة الإيجابية المفاجئة
CSTL تفوق 20 من 26 آخر التقديرات.
77%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$77.23M
/-$0.35
التغير الضمني من Q3 25 (Revenue/ EPS)
-7.00%
/+1650.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-10.52%
/-206.06%
Castle Biosciences, Inc. Common Stock earnings per share and revenue
On ٠٣ نوفمبر ٢٠٢٥, CSTL reported earnings of -0.02 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 96.25% surprise. Revenue reached 83.04 مليون, compared to an expected 72.63 مليون, with a 14.33% difference. The market reacted with a +21.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.35 USD, with revenue projected to reach 77.23 مليون USD, implying an زيادة of 1650.00% EPS, and نقصان of -7.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Castle Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Castle Biosciences, Inc. Common Stock reported EPS of -$0.02, beating estimates by 96.25%, and revenue of $83.04M, 14.33% above expectations.
How did the market react to Castle Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 21.7%, changed from $25.99 before the earnings release to $31.63 the day after.
When is Castle Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for Castle Biosciences, Inc. Common Stock's next earnings report?
Based on 10
المحللين, Castle Biosciences, Inc. Common Stock is expected to report EPS of -$0.35 and revenue of $77.23M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان